Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice
Authors:
- Ji-Yeon ShinJSJi-Yeon Shin
- Meredith RobertsMRMeredith Roberts
- Chuan-En WangCWChuan-En Wang
- Guoqing ShengGSGuoqing Sheng
- Shihua LiSLShihua Li
- Xiao-Jiang LiXLXiao-Jiang Li
Open Access
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (14) , 10653-10661
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's diseaseMolecular Neurodegeneration, 2007
- Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's DiseaseThe Journal of Neuroscience, 2003
- Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutationBrain, 2002
- Interaction of Huntington Disease Protein with Transcriptional Activator Sp1Molecular and Cellular Biology, 2002
- Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptomsJournal of Pharmacy and Pharmacology, 2001
- Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic MiceNeurobiology of Disease, 2001
- Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNANature Genetics, 1998
- GFAP Transgenic MiceMethods, 1996
- Chronobiological variations in the convulsive effect of monosodium L-glutamate when administered to adult rats.1995
- Monosodium-l-glutamate-induced convulsions—I. Differences in seizure pattern and duration of effect as a function of age in ratsGeneral Pharmacology: The Vascular System, 1984